Revolutionizing how we fight
antibiotic resistant bacteria

Get Started


ALEX is a tool that provides you with fully automated data analysis of your whole genome sequencing data enabling decision support for infectious diseases.

Request Trial


ALEX offers an all-in-one Software-as-a-Service with focus on antibiotic resistance and typing, enabling use for both surveillance and treatment decision support for clinicians and microbiologists.


The analysis runs with minimized hands-on effort and there is a strong focus on simplified and efficient result visualization for non-specialized users.


We are continuously updating the databases and extending the scope of the service by expanding software functionality and species coverage.

Version 1.0

The first version focuses on Staphylococcus aureus which is one of the most common pathogens in the hospital setting. When resistant to methicillin it is commonly called MRSA, which is a bacteria conferring serious infections and extensive problems for patients worldwide.

How does it work?

ALEX analyzes raw data from genome sequencing machines and matches the processed data to the proprietary databases that have been manually curated containing only clinical relevant genetic markers. The result in the form of a resistance and typing profile is delivered to the client in minutes.


Raw data generated by a sequencing machine is uploaded to our cloud based web-service.

Data analyzed

The data is analyzed and matched against our database of resistance and typing patterns.


The result is delivered back and can be used as a decision support for antibiotic treatment of the infected patient.

Antibiotic Resistance

Antibiotic resistance is one of the most serious threats to human health in modern times. The world is about to enter a post antibiotic era where minor infections will be lethal. Better diagnostic methods are needed to treat patients more efficiently and diminish the spread of antibiotic resistant bacteria.


Percentage of tested Staphylococcus aureus isolates that are methicillin resistant (MRSA), by country, 2011-2014

Source: CDDEP 2015, WHO 2014, and PAHO.


Percentage of tested Escherichia coli isolates producing extended-spectrum beta-lactamase (ESBL), by country, 2011-2014

Source: CDDEP 2015, WHO 2014, and PAHO.


Percentages of tested Klebsiella pneumoniae isolates that are carbapenem-resistant (CRKP), by country, 2011-2014

Source: CDDEP 2015, WHO 2014, and PAHO.

Why are we the best at solving this?

By being a front-runner in the technical development of personalized medicine, we have an unique position of addressing the global challenge of antibiotic resistance.

Reach Us

Feel free to contact us
if you’re interested in testing ALEX.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

We are hiring

Do you want to participate in the fight against antibiotic resistant bacteria? Join our dynamic development team and make a difference!

Currently we are looking for a Bioinformatician. Click here to go to the job page
Join us

Contact Us

1928 Diagnostics
Mailing adress: Stena Center 1D, 412 92
Visiting adress: Holtermansgatan 1, 411 29